Menon M, Tananis C E, Hicks L L, Hawkins E F, McLoughlin M G, Walsh P C
J Clin Invest. 1978 Jan;61(1):150-62. doi: 10.1172/JCI108913.
The potent synthetic androgen methytrienolone (R 1881), which does not bind to serum proteins, was utilized to characterize binding to receptors in human androgen responsive tissues. Cytosol extracts prepared from hypertrophic prostates (BPH) were utilized as the source of receptor for the initial studies. High affinity binding was detected in the cytosol of 29 of 30 samples of BPH (average number of binding sites, 45.8+/-4.7 fmol/mg of protein; dissociation constant, 0.9+/-0.2 nM). This binding had the characteristics of a receptor: heat lability, precipitability by 0-33% ammonium sulfate and by protamine sulfate, and 8S sedimentation coefficient. High affinity binding was also detected in cytosol prepared from seminal vesicle, epididymis, and genital skin but not in non-genital skin or muscle. However, similar binding was demonstrated in the cytosol of human uterus. The steroid specificities of binding to the cytosol of male tissues of accessory reproduction and of uterus were similar in that progestational agents were more effective competitors than natural androgens. Binding specificities in cytosol prepared from genital skin were distinctly different and were similar to those of ventral prostate from the castrated rat in that dihydrotestosterone was much more potent than progestins in competition. Thus binding of R 1881 to the cytosol of prostate, epididymis, and seminal vesicle has some characteristics of binding to a progesterone receptor. When the nuclear extract from BPH was analyzed, high affinity binding was demonstrated that conformed to the specificities of binding to an androgen receptor. Here dihydrotestosterone was a more potent competitor than progestational agents. Similar patterns of binding were detected in the crude nuclear extracts from seminal vesicle, epididymis, and genital skin but not in uterus, muscle, or non-genital skin. We conclude that the androgen receptor is not demonstrable in the cytosol of prostate, epididymis, or seminal vesicle of non-castrated men but can be measured in the cytosol of genital skin and the nuclear extracts of androgen responsive tissues. Because steroid hormones exert their major influence within the nucleus of target tissues, the measurement of nuclear receptor may provide valuable insight into the regulation of growth of target tissues.
强效合成雄激素甲基三烯醇酮(R1881)不与血清蛋白结合,被用于表征其与人雄激素反应性组织中受体的结合情况。最初的研究使用从增生性前列腺(良性前列腺增生)制备的胞质溶胶提取物作为受体来源。在30份良性前列腺增生样本中的29份的胞质溶胶中检测到高亲和力结合(结合位点平均数为45.8±4.7 fmol/mg蛋白质;解离常数为0.9±0.2 nM)。这种结合具有受体的特征:对热不稳定,可被0 - 33%硫酸铵和硫酸鱼精蛋白沉淀,沉降系数为8S。在精囊、附睾和生殖器皮肤制备的胞质溶胶中也检测到高亲和力结合,但在非生殖器皮肤或肌肉中未检测到。然而,在人子宫的胞质溶胶中也证明了类似的结合。与附属生殖器官的男性组织和子宫的胞质溶胶结合的类固醇特异性相似,即孕激素类药物比天然雄激素更有效地竞争结合。从生殖器皮肤制备的胞质溶胶中的结合特异性明显不同,与去势大鼠腹侧前列腺的结合特异性相似,即二氢睾酮在竞争结合中比孕激素更有效。因此,R1881与前列腺、附睾和精囊胞质溶胶的结合具有一些与孕激素受体结合的特征。当分析良性前列腺增生的核提取物时,证明了符合与雄激素受体结合特异性的高亲和力结合。在这里,二氢睾酮比孕激素类药物更有效地竞争结合。在精囊、附睾和生殖器皮肤的粗核提取物中检测到类似的结合模式,但在子宫、肌肉或非生殖器皮肤中未检测到。我们得出结论,在未去势男性的前列腺、附睾或精囊的胞质溶胶中未检测到雄激素受体,但可在生殖器皮肤的胞质溶胶和雄激素反应性组织的核提取物中进行测量。由于类固醇激素在靶组织细胞核内发挥主要作用,核受体的测量可能为深入了解靶组织生长的调节提供有价值的见解。